{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:02:13Z","timestamp":1779721333118,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["23C0012"],"award-info":[{"award-number":["23C0012"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["W20243280"],"award-info":[{"award-number":["W20243280"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ80707"],"award-info":[{"award-number":["2025JJ80707"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11909-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:41:14Z","timestamp":1779712874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Agmatine protects against MAFLD via decreasing RBM15\/IGF2BP2-mediated m6A modification of SREBP1"],"prefix":"10.1007","volume":"53","author":[{"given":"Guangkui","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"11909_CR1","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.2147\/DDDT.S514498","volume":"19","author":"Z Song","year":"2025","unstructured":"Song Z, Bu S, Sang S, Li J, Zhang X, Song X, Ran Y (2025) The active components of traditional chinese medicines regulate the multi-target signaling pathways of metabolic dysfunction-associated fatty liver disease. Drug Des Devel Ther 19:2693\u20132715","journal-title":"Drug Des Devel Ther"},{"key":"11909_CR2","doi-asserted-by":"publisher","first-page":"101372","DOI":"10.1016\/j.gendis.2024.101372","volume":"12","author":"S Hu","year":"2025","unstructured":"Hu S, Ai Y, Hu C, Cassim Bawa FN, Xu Y (2025) Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications. Genes Dis 12:101372","journal-title":"Genes Dis"},{"key":"11909_CR3","doi-asserted-by":"publisher","first-page":"e943417","DOI":"10.12659\/MSM.943417","volume":"30","author":"D Medina-Julio","year":"2024","unstructured":"Medina-Julio D, Ramirez-Mejia MM, Cordova-Gallardo J, Peniche-Luna E, Cantu-Brito C, Mendez-Sanchez N (2024) From liver to brain: How MAFLD\/MASLD impacts cognitive function. Med Sci Monit 30:e943417","journal-title":"Med Sci Monit"},{"key":"11909_CR4","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.3748\/wjg.v30.i23.2964","volume":"30","author":"J Rochon","year":"2024","unstructured":"Rochon J, Kalinowski P, Szymanek-Majchrzak K, Grat M (2024) Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 30:2964\u20132980","journal-title":"World J Gastroenterol"},{"key":"11909_CR5","doi-asserted-by":"publisher","first-page":"567654","DOI":"10.3389\/fmicb.2020.567654","volume":"11","author":"X Dai","year":"2020","unstructured":"Dai X, Hou H, Zhang W, Liu T, Li Y, Wang S, Wang B, Cao H (2020) Microbial metabolites: Critical regulators in NAFLD. Front Microbiol 11:567654","journal-title":"Front Microbiol"},{"key":"11909_CR6","doi-asserted-by":"crossref","unstructured":"Ku S, Park MS, Ji GE, You HJ (2016) Review on bifidobacterium bifidum BGN4: Functionality and nutraceutical applications as a probiotic microorganism. Int J Mol Sci 17: 1544","DOI":"10.3390\/ijms17091544"},{"key":"11909_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/10815589231204058","volume":"72","author":"G Bu","year":"2024","unstructured":"Bu G, Chen G, Li J, Wu D, Liao J (2024) Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway. J Investig Med 72:67\u201379","journal-title":"J Investig Med"},{"key":"11909_CR8","doi-asserted-by":"crossref","unstructured":"Wang L, Jiao T, Yu Q, Wang J, Wang L, Wang G, Zhang H, Zhao J, Chen W (2021) Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. Biomedicines 10: 84","DOI":"10.3390\/biomedicines10010084"},{"key":"11909_CR9","doi-asserted-by":"crossref","unstructured":"Lu J, Shataer D, Yan H, Dong X, Zhang M, Qin Y, Cui J, Wang L (2024) Probiotics and non-alcoholic fatty liver disease: Unveiling the mechanisms of lactobacillus plantarum and bifidobacterium bifidum in modulating lipid metabolism, inflammation, and intestinal barrier integrity. Foods 13: 2992","DOI":"10.3390\/foods13182992"},{"key":"11909_CR10","doi-asserted-by":"crossref","unstructured":"Wisniewska A, Stachowicz A, Kus K, Ulatowska-Bialas M, Toton-Zuranska J, Kiepura A, Stachyra K, Suski M, Gajda M, Jawien J, Olszanecki R (2021) Inhibition of atherosclerosis and liver steatosis by agmatine in Western Diet-Fed apoE-knockout mice is associated with decrease in hepatic de novo lipogenesis and reduction in plasma triglyceride\/high-density lipoprotein cholesterol ratio. Int J Mol Sci 22: 10688","DOI":"10.3390\/ijms221910688"},{"key":"11909_CR11","doi-asserted-by":"publisher","first-page":"102056","DOI":"10.1016\/j.arr.2023.102056","volume":"91","author":"P Saha","year":"2023","unstructured":"Saha P, Panda S, Holkar A, Vashishth R, Rana SS, Arumugam M, Ashraf GM, Haque S, Ahmad F (2023) Neuroprotection by agmatine: Possible involvement of the gut microbiome? Ageing Res Rev 91:102056","journal-title":"Ageing Res Rev"},{"key":"11909_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.31083\/j.fbl2812332","volume":"28","author":"S Zhao","year":"2023","unstructured":"Zhao S, Guo Y, Yin X (2023) Lipid peroxidation in ferroptosis and association with nonalcoholic fatty liver disease. Front Biosci (Landmark Ed) 28:332","journal-title":"Front Biosci (Landmark Ed)"},{"key":"11909_CR13","first-page":"174","volume":"11","author":"J Ji","year":"2023","unstructured":"Ji J, Wu L, Wei J, Wu J, Guo C (2023) The gut microbiome and ferroptosis in MAFLD. J Clin Transl Hepatol 11:174\u2013187","journal-title":"J Clin Transl Hepatol"},{"key":"11909_CR14","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.gendis.2023.04.022","volume":"11","author":"Y He","year":"2024","unstructured":"He Y, Qi S, Chen L, Zhu J, Liang L, Chen X, Zhang H, Zhuo L, Zhao S, Liu S, Xie T (2024) The roles and mechanisms of SREBP1 in cancer development and drug response. Genes Dis 11:100987","journal-title":"Genes Dis"},{"key":"11909_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1615\/CritRevImmunol.2024051934","volume":"44","author":"J Lang","year":"2024","unstructured":"Lang J, Luo J, Wang L, Xu W, Jia J, Zhao Z, Lang B (2024) Electroacupuncture suppresses oxidative stress and ferroptosis by activating the mTOR\/SREBP1 pathway in ischemic stroke. Crit Rev Immunol 44:99\u2013110","journal-title":"Crit Rev Immunol"},{"key":"11909_CR16","doi-asserted-by":"publisher","first-page":"e23806","DOI":"10.1096\/fj.202400721R","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang X, Chen Y, Meng H, Ruan J, Meng F (2024) SREBP-1-mediated lipogenesis confers resistance to ferroptosis and improves endothelial injury. FASEB J 38:e23806","journal-title":"FASEB J"},{"key":"11909_CR17","doi-asserted-by":"publisher","first-page":"e22227","DOI":"10.1002\/jbt.22227","volume":"32","author":"N Ahmed","year":"2018","unstructured":"Ahmed N, Aljuhani N, Al-Hujaili HS, Al-Hujaili MA, Elkablawy MA, Noah MM, Abo-Haded H, El-Agamy DS (2018) Agmatine protects against sodium valproate-induced hepatic injury in mice via modulation of nuclear factor-kappaB\/inducible nitric oxide synthetase pathway. J Biochem Mol Toxicol 32:e22227","journal-title":"J Biochem Mol Toxicol"},{"key":"11909_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10787-013-0188-2","volume":"22","author":"DS El-Agamy","year":"2014","unstructured":"El-Agamy DS, Makled MN, Gamil NM (2014) Protective effects of agmatine against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice. Inflammopharmacology 22:187\u2013194","journal-title":"Inflammopharmacology"},{"key":"11909_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.gendis.2023.02.054","volume":"11","author":"L Sun","year":"2024","unstructured":"Sun L, Chen X, Zhu S, Wang J, Diao S, Liu J, Xu J, Li X, Sun Y, Huang C et al (2024) Decoding m(6)A mRNA methylation by reader proteins in liver diseases. Genes Dis 11:711\u2013726","journal-title":"Genes Dis"},{"key":"11909_CR20","doi-asserted-by":"publisher","first-page":"116966","DOI":"10.1016\/j.biopha.2024.116966","volume":"177","author":"X Zha","year":"2024","unstructured":"Zha X, Gao Z, Li M, Xia X, Mao Z, Wang S (2024) Insight into the regulatory mechanism of m(6)A modification: From MAFLD to hepatocellular carcinoma. Biomed Pharmacother 177:116966","journal-title":"Biomed Pharmacother"},{"key":"11909_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"11909_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","volume":"29","author":"J Fang","year":"2023","unstructured":"Fang J, Wu X, He J, Zhang H, Chen X, Zhang H, Novakovic B, Qi H, Yu X (2023) RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Mol Med 29:23","journal-title":"Mol Med"},{"key":"11909_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","volume":"44","author":"J Tong","year":"2023","unstructured":"Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, Ou-Yang SX, Zhuang CL, Shen FM, Wang P, Li DJ (2023) Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin 44:1014\u20131028","journal-title":"Acta Pharmacol Sin"},{"key":"11909_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jhep.2022.08.008","volume":"78","author":"A Hadjihambi","year":"2023","unstructured":"Hadjihambi A, Konstantinou C, Klohs J, Monsorno K, Le Guennec A, Donnelly C, Cox IJ, Kusumbe A, Hosford PS, Soffientini U et al (2023) Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction. J Hepatol 78:180\u2013190","journal-title":"J Hepatol"},{"key":"11909_CR25","first-page":"1034","volume":"10","author":"Q Yu","year":"2022","unstructured":"Yu Q, He R, Jiang H, Wu J, Xi Z, He K, Liu Y, Zhou T, Feng M, Wan P et al (2022) Association between metabolic dysfunction-associated fatty liver disease and cognitive impairment. J Clin Transl Hepatol 10:1034\u20131041","journal-title":"J Clin Transl Hepatol"},{"key":"11909_CR26","doi-asserted-by":"publisher","first-page":"100992","DOI":"10.1016\/j.jhepr.2023.100992","volume":"6","author":"K Kjaergaard","year":"2024","unstructured":"Kjaergaard K, Daugaard Mikkelsen AC, Landau AM, Eriksen PL, Hamilton-Dutoit S, Magnusson NE, Thomsen MB, Chen F, Vilstrup H, Mookerjee RP et al (2024) Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. JHEP Rep 6:100992","journal-title":"JHEP Rep"},{"key":"11909_CR27","doi-asserted-by":"crossref","unstructured":"Zamanian MY, Nazifi M, Khachatryan LG, Taheri N, Ivraghi MS, Menon SV, Husseen B, Prasad KDV, Petkov I, Nikbakht N (2024) The neuroprotective effects of agmatine on parkinson\u2019s disease: focus on oxidative stress, inflammation and molecular mechanisms. Inflammation 48: 1078-1092","DOI":"10.1007\/s10753-024-02139-7"},{"key":"11909_CR28","doi-asserted-by":"publisher","first-page":"204201882412429","DOI":"10.1177\/20420188241242937","volume":"15","author":"W Alghamdi","year":"2024","unstructured":"Alghamdi W, Mosli M, Alqahtani SA (2024) Gut microbiota in MAFLD: therapeutic and diagnostic implications. Ther Adv Endocrinol Metab 15:20420188241242937","journal-title":"Ther Adv Endocrinol Metab"},{"key":"11909_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ecl.2023.01.004","volume":"52","author":"TM Barber","year":"2023","unstructured":"Barber TM, Hanson P, Weickert MO (2023) Metabolic-associated fatty liver disease and the gut microbiota. Endocrinol Metab Clin North Am 52:485\u2013496","journal-title":"Endocrinol Metab Clin North Am"},{"key":"11909_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00726-019-02720-7","volume":"52","author":"N Akasaka","year":"2020","unstructured":"Akasaka N, Fujiwara S (2020) The therapeutic and nutraceutical potential of agmatine, and its enhanced production using Aspergillus oryzae. Amino Acids 52:181\u2013197","journal-title":"Amino Acids"},{"key":"11909_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.10.013","volume":"191","author":"Chronic agmatine treatment","year":"2022","unstructured":"Chronic agmatine treatment (2022) prevents olanzapine-induced obesity and metabolic dysregulation in female rats. Brain Res Bull 191:69\u201377","journal-title":"Brain Res Bull"},{"key":"11909_CR32","doi-asserted-by":"publisher","first-page":"e3124","DOI":"10.1002\/brb3.3124","volume":"13","author":"S Ganjalikhan-Hakemi","year":"2023","unstructured":"Ganjalikhan-Hakemi S, Asadi-Shekaari M, Pourjafari F, Asadikaram G, Nozari M (2023) Agmatine improves liver function, balance performance, and neuronal damage in a hepatic encephalopathy induced by bile duct ligation. Brain Behav 13:e3124","journal-title":"Brain Behav"},{"key":"11909_CR33","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/TP.0000000000003161","volume":"104","author":"Z Han","year":"2020","unstructured":"Han Z, Li Y, Yang B, Tan R, Wang M, Zhang B, Dai C, Wei L, Chen D, Chen Z (2020) Agmatine attenuates liver ischemia reperfusion injury by activating Wnt\/beta-catenin signaling in mice. Transplantation 104:1906\u20131916","journal-title":"Transplantation"},{"key":"11909_CR34","doi-asserted-by":"publisher","first-page":"960327122111085","DOI":"10.1177\/09603271221110857","volume":"41","author":"D Zhang","year":"2022","unstructured":"Zhang D, Li J, Li T (2022) Agmatine mitigates palmitate (PA)-induced mitochondrial and metabolic dysfunction in microvascular endothelial cells. Hum Exp Toxicol 41:9603271221110857","journal-title":"Hum Exp Toxicol"},{"key":"11909_CR35","doi-asserted-by":"publisher","first-page":"e2149","DOI":"10.1002\/biof.2149","volume":"51","author":"K Milosevic","year":"2025","unstructured":"Milosevic K, Milosevic A, Stevanovic I, Zivkovic A, Laketa D, Janjic MM, Bjelobaba I, Lavrnja I, Savic D (2025) Agmatine suppresses glycolysis via the PI3K\/Akt\/mTOR\/HIF-1alpha signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide. BioFactors 51:e2149","journal-title":"BioFactors"},{"key":"11909_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13105-021-00799-9","volume":"77","author":"AE Gheit","year":"2021","unstructured":"Gheit AE, Soliman RE, Badawi NA, Madi GA, El-Saka NM, Badr MH, Emam SM (2021) Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection: Agmatine in diabetic retinopathy. J Physiol Biochem 77:305\u2013320","journal-title":"J Physiol Biochem"},{"key":"11909_CR37","doi-asserted-by":"publisher","first-page":"176884","DOI":"10.1016\/j.ejphar.2024.176884","volume":"981","author":"S Rahangdale","year":"2024","unstructured":"Rahangdale S, Deshmukh P, Sammeta S, Aglawe M, Kale M, Umekar M, Kotagale N, Taksande B (2024) Agmatine modulation of gut-brain axis alleviates dysbiosis-induced depression-like behavior in rats. Eur J Pharmacol 981:176884","journal-title":"Eur J Pharmacol"},{"key":"11909_CR38","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","volume":"53","author":"AE Freitas","year":"2016","unstructured":"Freitas AE, Egea J, Buendia I, Gomez-Rangel V, Parada E, Navarro E, Casas AI, Wojnicz A, Ortiz JA, Cuadrado A et al (2016) Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice. Mol Neurobiol 53:3030\u20133045","journal-title":"Mol Neurobiol"},{"key":"11909_CR39","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.molmet.2022.101584","volume":"65","author":"W Luo","year":"2022","unstructured":"Luo W, Dai J, Liu J, Huang Y, Zheng Z, Xu P, Ma Y (2022) PACAP attenuates hepatic lipid accumulation through the FAIM\/AMPK\/IRbeta axis during overnutrition. Mol Metab 65:101584","journal-title":"Mol Metab"},{"key":"11909_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2022.12.087","volume":"195","author":"D Lin","year":"2023","unstructured":"Lin D, Sun Q, Liu Z, Pan J, Zhu J, Wang S, Jia S, Zheng M, Li X, Gong F (2023) Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. Free Radic Biol Med 195:199\u2013218","journal-title":"Free Radic Biol Med"},{"key":"11909_CR41","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"YC Wu","year":"2024","unstructured":"Wu YC, Yan Q, Yue SQ, Pan LX, Yang DS, Tao LS, Wei ZY, Rong F, Qian C, Han MQ et al (2024) NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci 20:2219\u20132235","journal-title":"Int J Biol Sci"},{"key":"11909_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/HEP.0000000000000643","volume":"81","author":"C Ke","year":"2025","unstructured":"Ke C, Xiao C, Li J, Wu X, Zhang Y, Chen Y, Sheng S, Fu Z, Wang L, Ni C et al (2025) FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1. Hepatology 81:181\u2013197","journal-title":"Hepatology"},{"key":"11909_CR43","doi-asserted-by":"publisher","first-page":"155437","DOI":"10.1016\/j.phymed.2024.155437","volume":"126","author":"Y Liu","year":"2024","unstructured":"Liu Y, Sun Z, Dong R, Liu P, Zhang X, Li Y, Lai X, Cheong HF, Wu Y, Wang Y et al (2024) Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK\/SREBP1 pathway. Phytomedicine 126:155437","journal-title":"Phytomedicine"},{"key":"11909_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/biof.1927","volume":"49","author":"W Xu","year":"2023","unstructured":"Xu W, Ding J, Li B, Sun T, You X, He Q, Sheng W (2023) Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7\/m-TOR\/SREBP1 pathway on prostate cancer. BioFactors 49:438\u2013456","journal-title":"BioFactors"},{"key":"11909_CR45","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41419-024-06848-7","volume":"15","author":"YN Zheng","year":"2024","unstructured":"Zheng YN, Lou SY, Lu J, Zheng FL, Tang YM, Zhang EJ, Cui SL, Zhao HJ (2024) Selective PI3Kdelta inhibitor TYM-3-98 suppresses AKT\/mTOR\/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer. Cell Death Dis 15:474","journal-title":"Cell Death Dis"},{"key":"11909_CR46","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, Zhang L, Yang L, Gu C, Huang X et al (2022) Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther 30:2342\u20132353","journal-title":"Mol Ther"},{"key":"11909_CR47","doi-asserted-by":"publisher","first-page":"e0046","DOI":"10.1097\/HC9.0000000000000046","volume":"7","author":"J Tan","year":"2023","unstructured":"Tan J, Wang YF, Dai ZH, Yin HZ, Mu CY, Wang SJ, Yang F (2023) Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatol Commun 7:e0046","journal-title":"Hepatol Commun"},{"key":"11909_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s11658-025-00723-9","volume":"30","author":"S Liu","year":"2025","unstructured":"Liu S, Liao S, He J, Zhou Y, He Q (2025) IGF2BP2: an m(6)A reader that affects cellular function and disease progression. Cell Mol Biol Lett 30:43","journal-title":"Cell Mol Biol Lett"},{"key":"11909_CR49","doi-asserted-by":"publisher","first-page":"11944","DOI":"10.1074\/jbc.RA119.008778","volume":"294","author":"L Regue","year":"2019","unstructured":"Regue L, Minichiello L, Avruch J, Dai N (2019) Liver-specific deletion of IGF2 mRNA binding protein-2\/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation. J Biol Chem 294:11944\u201311951","journal-title":"J Biol Chem"},{"key":"11909_CR50","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s42255-021-00488-3","volume":"3","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Peng J, Song J, He J, Jiang M, Wang J, Ma L, Wang Y, Lin M, Wu H et al (2021) Loss of Hilnc prevents diet-induced hepatic steatosis through binding of IGF2BP2. Nat Metab 3:1569\u20131584","journal-title":"Nat Metab"},{"key":"11909_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10142-025-01809-5","volume":"26","author":"M Liu","year":"2026","unstructured":"Liu M, Cao L, Fan Z, Qu N, Luan T, Chen Y, Bian H, Wang Z, Zhang K, Chen L (2026) LncRNA TUG1 promotes hepatic lipid accumulation by targeting the miR-29a-3p\/SREBP-2\/HMGCR axis in MAFLD. Funct Integr Genomics 26:34","journal-title":"Funct Integr Genomics"},{"key":"11909_CR52","doi-asserted-by":"publisher","first-page":"e16246","DOI":"10.1111\/liv.16246","volume":"45","author":"H Wang","year":"2025","unstructured":"Wang H, Guo M, Cui F, Li M, Zhang X, Gao W, Fang X, Chen L, Xin Y, Sun Y et al (2025) miR-18a-5p\/PXR\/SREBP2 Was Involved in MAFLD Associated With Methyl Tert-Butyl Ether Among Petrol Station Workers. Liver Int 45:e16246","journal-title":"Liver Int"},{"key":"11909_CR53","doi-asserted-by":"publisher","first-page":"116060","DOI":"10.1016\/j.biopha.2023.116060","volume":"170","author":"Q Xia","year":"2024","unstructured":"Xia Q, Lu F, Chen Y, Li J, Huang Z, Fang K, Hu M, Guo Y, Dong H, Xu L, Gong J (2024) 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway. Biomed Pharmacother 170:116060","journal-title":"Biomed Pharmacother"},{"key":"11909_CR54","doi-asserted-by":"crossref","unstructured":"Yang M, Gallo-Ebert C, Hayward M, Liu W, McDonough V, Nickels JT Jr. (2020) Human insulin growth factor 2 mRNA binding protein 2 increases MicroRNA 33a\/b inhibition of liver ABCA1 expression and alters low-density apolipoprotein levels in mice. Mol Cell Biol 40: e00058-20","DOI":"10.1128\/MCB.00058-20"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11909-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:02:14Z","timestamp":1779717734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11909-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11909"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11909-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was approved by the Ethics Committee of The First Affiliated Hospital of Guangxi Medical University. All the animal procedures were performed in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"821"}}